Galderma Successfully Completes Acquisition of ALASTIN Skincare
Galderma announces that it has received antitrust clearance from the US authorities and has completed the acquisition of ALASTIN Skincare Inc.
Galderma announces that it has received antitrust clearance from the US authorities and has completed the acquisition of ALASTIN Skincare Inc.
Autologous Spray-On Skin Cells are expanding what's possible in reconstructive surgery. By reducing donor skin requirements and supporting faster, more natural healing, the technology is helping surgeons improve both functional and aesthetic outcomes while reshaping the approach to burns, traumatic wounds, and complex reconstruction.